Literature DB >> 16103735

Anti-progressive effect of neutral endopeptidase 24.11 (NEP/CD10) on cervical carcinoma in vitro and in vivo.

Mikio Terauchi1, Hiroaki Kajiyama, Kiyosumi Shibata, Kazuhiko Ino, Shigehiko Mizutani, Fumitaka Kikkawa.   

Abstract

OBJECTIVES: Neutral endopeptidase 24.11 (NEP) is known to play important roles in the maintenance of homeostasis or in neoplastic transformation and tumor progression in certain human malignancies through the enzymatic inactivation of bioactive peptides such as endothelin-1 (ET-1), angiotensin-II, and bombesin.
METHODS: In this study, we first investigated NEP expression in cervical carcinoma by immunohistochemical staining and Western blot analysis. Next, we examined NEP functions in vitro and in vivo by generating NEP-overexpressing cervical carcinoma cells.
RESULTS: We found a significant decrease in cellular proliferative and invasive abilities with a reduced ET-1 concentration in the conditioned medium by NEP overexpression in cervical carcinoma CaSki cells, which have an ET-1 autocrine loop. In addition, these potentials were cancelled by blockade of NEP activity with a specific inhibitor. Although vector-transfected CaSki cells could grow even in serum-free media, NEP-overexpressing cells failed to proliferate in these media. Furthermore, we demonstrated that NEP suppressed tumor formation of subcutaneous xenografts using nude mice.
CONCLUSIONS: Our results indicated that NEP functions as a tumor-suppressor gene in cervical carcinoma cells, and its expression may have prognostic significance. Further elucidation of the mechanism underlying the observed effect of NEP will contribute to a better understanding of its role in the pathophysiology of cervical carcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103735     DOI: 10.1159/000087476

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  15 in total

1.  Characterization of LHY-821, a novel moderately differentiated endometrial carcinoma cell line.

Authors:  Qian Hu; Li Yu; Rui Chen; Yan Zhang; Ya Xie; Qinping Liao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-07-18       Impact factor: 2.416

Review 2.  Long-term neprilysin inhibition - implications for ARNIs.

Authors:  Duncan J Campbell
Journal:  Nat Rev Cardiol       Date:  2016-12-15       Impact factor: 32.419

3.  Neuropeptide Levels as well as Neprilysin Activity Decrease in Renal Cell Carcinoma.

Authors:  Nuray Erin; Tümay İpekçi; Bahar Akkaya; İrem Hicran Özbudak; Mehmet Baykara
Journal:  Cancer Microenviron       Date:  2016-10-19

4.  CD10 Is Again Expressed at a Certain Stage during the Neoplastic Process of Bladder Transitional Cell Carcinomas.

Authors:  Tae Jung Jang
Journal:  Cancer Res Treat       Date:  2012-12-31       Impact factor: 4.679

5.  Synergistic relationship between dipeptidyl peptidase IV and neutral endopeptidase expression and the combined prognostic significance in osteosarcoma patients.

Authors:  Hongtao Zhang; Haibin Lin; Xiaoqiong Mo; Guoli Chen; Lijun Lin
Journal:  Med Oncol       Date:  2013-05-18       Impact factor: 3.064

Review 6.  Potential Expanded Indications for Neprilysin Inhibitors.

Authors:  Elizabeth Riddell; Justin M Vader
Journal:  Curr Heart Fail Rep       Date:  2017-04

7.  Establishment of a new cell line of endometrioid carcinoma of the ovary and its chemosensitivity.

Authors:  Tomokazu Umezu; Hiroaki Kajiyama; Mikio Terauchi; Kiyosumi Shibata; Kazuhiko Ino; Akihiro Nawa; Fumitaka Kikkawa
Journal:  Hum Cell       Date:  2007-08       Impact factor: 4.174

Review 8.  Extracellular molecules involved in cancer cell invasion.

Authors:  Theodora Stivarou; Evangelia Patsavoudi
Journal:  Cancers (Basel)       Date:  2015-01-26       Impact factor: 6.639

9.  Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation.

Authors:  W T Arscott; A E LaBauve; V May; U V Wesley
Journal:  Oncogene       Date:  2008-11-03       Impact factor: 9.867

10.  Prognostic significance of the combined expression of neutral endopeptidase and dipeptidyl peptidase IV in intrahepatic cholangiocarcinoma patients after surgery resection.

Authors:  Jianyong Zhu; Xiaodong Guo; Baoan Qiu; Zhiyan Li; Nianxin Xia; Yingxiang Yang; Peng Liu
Journal:  Onco Targets Ther       Date:  2014-02-17       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.